Shangpu Group Issues Market Position Statement Recognizing SALIAI's Patented Cellular Essence Global Pioneer
Shangpu Group Issues Market Position Statement Recognizing SALIAI's Patented Cellular Essence Global Pioneer is drawing significant interest across the industry.
BEIJING and GUANGZHOU, China, March 2, 2026 /PRNewswire/ -- SALIAI ('Guangzhou SALIAI Stem Cell Science and Technology Co., Ltd.' and 'Guangzhou SALIAI Biological Gene Engineering Co., Ltd.,' collectively referred to as 'SALIAI') is a China-based biotechnology company engaged in stem cell research and related commercial applications. The Company states that it was the first stem cell-focused company quoted on the National Equities Exchange and Quotations (NEEQ), China's New Third Board market.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Smart glasses, AirPods camera and 1 more: Apple tipped to launch these AI gadgets soon
- Sedemac Mechatronics IPO Day 3: GMP, subscription status, key details
- Emirates issues Dubai flights update as travel to UK airports resumes
- Airline and travel industries scramble with fallout from Middle Eastern conflict
Source: Original →